From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents

被引：0
|
作者：
Caprio, Massimiliano [1 ,2 ]
Vitale, Cristiana [3 ]
Rosano, Giuseppe M. C. [3 ]
机构：
[1] IRCCS San Raffaele Pisana, Lab Cardiovasc Endocrinol, Rome, Italy
[2] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, Rome, Italy
[3] IRCCS San Raffaele, Dept Cardiovasc & Resp Sci, Rome, Italy
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2021年 / 7卷 / 02期
关键词：
ACUTE MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; INSULIN-GLUCOSE; MORTALITY; LIRAGLUTIDE; PREVALENCE; OUTCOMES; RISK;
D O I：
10.1093/ehjcvp/pvaa019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 85
页数：3
相关论文
共 50 条
  • [41] Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
    Lo, Clement
    Toyama, Tadashi
    Wang, Ying
    Lin, Jin
    Hirakawa, Yoichiro
    Jun, Min
    Cass, Alan
    Hawley, Carmel M.
    Pilmore, Helen
    Badve, Sunil V.
    Perkovic, Vlado
    Zoungas, Sophia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (09):
  • [42] Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease
    Inzucchi, Silvio E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 137 - +
  • [43] Recent advances in glucose-lowering treatment to reduce diabetic kidney disease
    Hanssen, Nordin M. J.
    Russell, Nicholas
    Cooper, Mark E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (09) : 1325 - 1333
  • [44] Pragmatic trials, a step forward to assess cardiovascular efficacy of new glucose-lowering agents
    Scheen, Andre
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (09): : 626 - 627
  • [45] The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
    Agrawal, V.
    Giri, C.
    Solomon, R. J.
    CURRENT DIABETES REVIEWS, 2015, 11 (03) : 191 - 200
  • [46] Statin and glucose-lowering treatment in individuals with and without schizophrenia
    Eriksson, S. V. E. N.
    Eberhard, J.
    Osby, U.
    Westman, J.
    Forslund, L.
    Wallen, J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1509 - 1509
  • [47] Pharmacogenetics of glucose-lowering drug treatment - A Systematic review
    Bozkurt, Oezlem
    de Boer, Anthonius
    Grobbee, Diederick E.
    Heerdink, Eibert R.
    Burger, Huib
    Klungel, Olaf H.
    MOLECULAR DIAGNOSIS & THERAPY, 2007, 11 (05) : 291 - 302
  • [48] The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis
    Nasrallah, Mona P.
    Abi-Khalil, Charbel
    Refaat, Marwan M.
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [49] Acute glucose-lowering effects of Thiazolodinediones
    Luo, J
    Nguyen, K
    Kim, Y
    Chen, M
    Sims, C
    Tran, T
    Luskey, K
    DIABETES, 2001, 50 : A516 - A517
  • [50] Pharmacogenetics of novel glucose-lowering drugs
    Wolfgang Rathmann
    Brenda Bongaerts
    Diabetologia, 2021, 64 : 1201 - 1212
12345